- Published
- 02 April 2021
- Journal article
Management of anaphylaxis due to COVID-19 vaccines in the elderly
- Authors
-
- Source
- Allergy
Full text
Abstract
Older adults, especially men and/or those with diabetes, hypertension and/or obesity, are prone to severe COVID-19. In some countries, older adults, particularly those residing in nursing homes, have been prioritised to receive COVID-19 vaccines due to high risk of death. In very rare instances,the COVID-19 vaccines can induce anaphylaxis, and the management of anaphylaxis in older people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis and its Impact on Asthma, European Academy of Allergy and Clinical Immunology, and European Geriatric Medicine Society)Working Group has proposed some recommendations for older adults receiving the COVID-19 vaccines. Anaphylaxis to COVID-19 vaccines is extremely rare (from 1 per 100,000 to 5 per million injections). Symptoms are similar in younger and older adults but they tend to be more severe in the older patients. Adrenaline is the mainstay treatment and should be readily available. A flowchart is proposed to manage anaphylaxis in the older patients.
Rights
This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.
Cite as
Bousquet, J., Agache, I., Blain, H., Jutel, M., Ventura, M., Worm, M., Del Giacco, S., Benetos, A., Bilo, M., Czarlewski, W., Latiff, A., Al-Ahmad, M., Angier, E., Annesi-Maesano, I., Atanaskovic-Markovic, M., Bachert, C., Barbaud, A., Bedbrook, A., Bennoor, K., Berghea, E., Bindslev-Jensen, C., Bonini, S., Bosnic-Anticevich, S., Brockow, K., Brussino, L., Camargos, P., Canonica, G., Cardona, V., Carreiro‐Martins, P., Carriazo, A., Casale, T., Caubet, J., Cecchi, L., Cherubini, A., Christoff, G., Chu, D., Cruz, A., Dokic, D., El-Gamal, Y., Ebisawa, M., Eberlein, B., Farrell, J., Fernandez-Rivas, M., Fokkens, W., Fonseca, J., Gao, Y., Gavazzi, G., Gawlik, R., Gelincik, A., Gemicioğlu, B., Gotua, M., Guérin, O., Haahtela, T., Hoffmann‐Sommergruber, K., Hoffmann, H., Hoffmann, M., Hrubisko, M., Illario, M., Irani, C., Ispayeva, Z., Ivancevich, J., Julge, K., Kaidashev, I., Khaitov, M., Knol, E., Kraxner, H., Kuna, P., Kvedariene, V., Lauerma, A., Le, L., Le Moing, V., Levin, M., Louis, R., Lourenco, O., Mahler, V., Martin, F., Matucci, A., Milenkovic, B., Miot, S., Montella, E., Morais-Almeida, M., Mortz, C., Mullol, J., Namazova-Baranova, L., Neffen, H., Nekam, K., Niedoszytko, M., Odemyr, M., O'Hehir, R., Okamoto, Y., Ollert, M., Palomares, O., Papadopoulos, N., Panzner, P., Passalacqua, G., Patella, V., Petrovic, M., Pfaar, O., Pham-Thi, N., Plavec, D., Popov, T., Recto, M., Regateiro, F., Reynes, J., Roller-Winsberger, R., Rolland, Y., Romano, A., Rondon, C., Rottem, M., Rouadi, P., Salles, N., Samolinski, B., Santos, A., Serpa, F., Sastre, J., Schols, J., Scichilone, N., Sediva, A., Shamji, M., Sheikh, A., Skypala, I., Smolinska, S., Sokolowska, M., Sousa-Pinto, B., Sova, M., Stelmach, R., Sturm, G., Ulrik, C., Todo-Bom, A., Toppila-Salmi, S., Tsiligianni, I., Torres, M., Untersmayr, E., Pereira, M., Valiulis, A., Vitte, J., Vultaggio, A., Wallace, D., Walusiak‐Skorupa, J., Wang, D., Waserman, S., Yorgancioglu, A., Yusuf, O., Zernotti, M., Zidarn, M., Chivato, T., Akdis, C., Zuberbier, T. & Klimek, L. 2021, 'Management of anaphylaxis due to COVID-19 vaccines in the elderly', Allergy. https://doi.org/10.1111/all.14838